CrushSCI.com
481.5Average days
421.5Median days
50Fastest days
2,066Longest days
922025 publications

Paper Review Records

All Paper Review Records

16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

56 days

ctDNA Positivity Is Not a Treatment Indication: Defining the Actionability Threshold for Molecular Residual Disease

Authors
Jian Zheng; Yong GuoShow moreShow less
Affiliations
1. Department of Oncology, Zhejiang Provincial Hospital of Chinese Medicine, The First Affiliated Hospital of Zhejiang University of Traditional Chinese MedicineShow moreShow less
Source PDF DOI Publisher page
432 days

Recent Advances in Synovial Sarcoma: Molecular Insights and Evolving Pharmacological Therapies

Authors
Jayaraman Rajangam; Shravan Venkatraman; Prakash Ramakrishan; Agasa Ramu Mahesh; Parasuraman Pavadai; Shradha Bisht; Muddukrishnaiah Kotakonda; Sittarthan Viswanathan; P. Dharani PrasadShow moreShow less
Affiliations
1. Department of Pharmacology, Shri Venkateshwara College of Pharmacy, Ariyur; 2. Department of Pharmacology, Sri Manakula Vinayagar Medical College and Hospital; 3. Department of Pharmacology, Crescent School of Pharmacy, B. S. Abdur Rahman Crescent Institute of Science & Technology-BSACIST University; 4. Department of Pharmaceutical Chemistry, The Oxford College of Pharmacy, Hongasandra; 5. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, M. S. Ramaiah University of Applied Sciences; 6. Department of Pharmacology, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University; 7. Department of Pharmaceutics, Jamia Salafiya Pharmacy College; 8. Department of Pharmacology, Mohan Babu UniversityShow moreShow less
Source PDF DOI Publisher page
159 days

The Microbiome-Arginine-Immune Axis in Oral Squamous Cell Carcinoma: Metabolic Competition and Therapeutic Opportunities

Authors
Priya Ramachandran; Ritika Gopalakrishnan; Ragul Gunasekaran; Kamala Kannan; Dhanraj Ganapathy; Sivaperumal PitchiahShow moreShow less
Affiliations
1. Centre for Marine and Aquatic Research (CMAR), Saveetha Institute of Medical and Technical Sciences, Saveetha University; 2. Department of Prosthodontics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Velappanchavadi; 3. Department of Marine Sciences, Saveetha Institute of Natural and Physical Sciences (SINAPS), Saveetha Institute of Medical and Technical Sciences, Saveetha UniversityShow moreShow less
Source PDF DOI Publisher page
50 days

Exploratory Single-Cell Analysis of NK-Annotated Cells Across Marrow Compartments in Prostate Cancer Bone Metastasis

Authors
Kehao Pan; Nianzeng XingShow moreShow less
Affiliations
1. Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; 2. State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; 3. Beijing Key Laboratory of Urologic Cancer Cell and Gene Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeShow moreShow less
Source PDF DOI Publisher page
119 days

Cancer-Associated Fibroblast Exosomes in Breast Cancer: Mechanisms of Tumor-Stroma Crosstalk and Clinical Implications

Authors
Arezoo Ghareh-Hasanlou; Negar Yavari Tehrani-Fard; Parastoo Akbarabadi; Maryam Etesami; Sara Zareian; Roudabeh Behzadi-Andouhjerdi; Zeinab Piravar; Sadegh BabashahShow moreShow less
Affiliations
1. Department of Genetics, Faculty of Basic Sciences, Central Tehran Branch, Islamic Azad University; 2. Department of Molecular Medicine, Qazvin University of Medical Sciences; 3. Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares UniversityShow moreShow less
Source PDF DOI Publisher page
68 days

Assessment of Adverse Drug Reaction, Medication Adherence and Quality of Life in Breast Cancer Patients: A Prospective Observational Study

Authors
Mohamed Akram Ali S; Hariharan B; Sathishkumar K; Somasundram C; Tharun B; Vijayasakthi MShow moreShow less
Affiliations
1. Department of Pharmacy Practice, Sri Shanmugha College of PharmacyShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does CANCER INVESTIGATION take to review a manuscript?

As of 2026-11-19, CrushSCI has 16 complete review records for CANCER INVESTIGATION. The fastest paper went from submission to acceptance in 50 days (Exploratory Single-Cell Analysis of NK-Annotated Cells Across Marrow Compartments in Prostate Cancer Bone Metastasis, received 2026-08-11, accepted 2026-09-30); the slowest took 2066 days. The average is 481.5 days and the median is 421.5 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.